TY - JOUR
T1 - Building a certificate-based secure and quick response telemedical health-care system for diabetic patients
AU - Chien, Ming Nan
AU - Liu, Li
AU - Chiang, Hsui Ching
AU - Wu, Chi-Cheng
AU - Lee, Yann Jinn
AU - Huang, Chen Ling
AU - Lee, Chun Chuan
AU - Leung, Ching Hsiang
AU - Wang, Chao Hung
PY - 2006/4
Y1 - 2006/4
N2 - The internet has begun to play a greater role in many health-care processes. To improve the quality of diabetes control while safeguarding and keeping the patient's information confidential, a certificate-based and quick response telemedical health-care system can be used to devise a program which allows patients with diabetes to transmit their self-monitored blood glucose data directly from their personal glucometer device to their diabetes care provider over the internet. The system can integrate the remotely transmitted glycemic data to a secure database for retrieval by physician to analyze at a later time. If unusual or alarming trends are detected by an intelligent agent (IA) system, both the physician and patient are notified of the occurrence. Patients are also allowed to access clinical data through web-based interface. We hope that this initiative can improve the quality of diabetic care. The aim of this study was to evaluate the effectiveness of a quick response telemedical health-care model to biomonitor type 2 diabetic patients attending the diabetic OPD of Mackay Memorial Hospital and Taipei Medical University Hospital. A total of 134 unrelated type 2 diabetic patients were included in a 6-month prospective study. They were categorized into either the experimental or the control group. The experimental group was monitored using our telemedical health-care system for 6 months. The control group received the usual outpatient management over the same period. We compared the differences in HbA1c and fasting plasma glucose levels before and at the end of the study, both in each group as well as between the experimental group and the control group. Initially, there is no significant difference in either fasting glucose levels or HbA1c between the experimental group and control group. At the end of the study (6 months later), there were significant changes in fasting plasma glucose when compared with the initial data, both in the experimental group (179±61 mg/dl vs. 241±77 mg/dl, p
AB - The internet has begun to play a greater role in many health-care processes. To improve the quality of diabetes control while safeguarding and keeping the patient's information confidential, a certificate-based and quick response telemedical health-care system can be used to devise a program which allows patients with diabetes to transmit their self-monitored blood glucose data directly from their personal glucometer device to their diabetes care provider over the internet. The system can integrate the remotely transmitted glycemic data to a secure database for retrieval by physician to analyze at a later time. If unusual or alarming trends are detected by an intelligent agent (IA) system, both the physician and patient are notified of the occurrence. Patients are also allowed to access clinical data through web-based interface. We hope that this initiative can improve the quality of diabetic care. The aim of this study was to evaluate the effectiveness of a quick response telemedical health-care model to biomonitor type 2 diabetic patients attending the diabetic OPD of Mackay Memorial Hospital and Taipei Medical University Hospital. A total of 134 unrelated type 2 diabetic patients were included in a 6-month prospective study. They were categorized into either the experimental or the control group. The experimental group was monitored using our telemedical health-care system for 6 months. The control group received the usual outpatient management over the same period. We compared the differences in HbA1c and fasting plasma glucose levels before and at the end of the study, both in each group as well as between the experimental group and the control group. Initially, there is no significant difference in either fasting glucose levels or HbA1c between the experimental group and control group. At the end of the study (6 months later), there were significant changes in fasting plasma glucose when compared with the initial data, both in the experimental group (179±61 mg/dl vs. 241±77 mg/dl, p
KW - Diabetes mellitus
KW - Fasting plasma glucose
KW - HbA1c, hemoglobin A1c
KW - Public infrastructure
KW - Quick response
KW - Telemedicinal health-care
UR - http://www.scopus.com/inward/record.url?scp=33745472921&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33745472921&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:33745472921
SN - 1016-7390
VL - 17
SP - 61
EP - 72
JO - Journal of Internal Medicine of Taiwan
JF - Journal of Internal Medicine of Taiwan
IS - 2
ER -
